Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Spironolactone suppresses peritubular capillary loss and prevents deoxycorticosterone acetate/salt-induced tubulointerstitial fibrosis.

Iwazu Y, Muto S, Fujisawa G, Nakazawa E, Okada K, Ishibashi S, Kusano E.

Hypertension. 2008 Mar;51(3):749-54. doi: 10.1161/HYPERTENSIONAHA.107.104901. Epub 2008 Feb 4.

2.

Role of impaired peritubular capillary and hypoxia in progressive interstitial fibrosis after 56 subtotal nephrectomy of rats.

Zhang B, Liang X, Shi W, Ye Z, He C, Hu X, Liu S.

Nephrology (Carlton). 2005 Aug;10(4):351-7.

PMID:
16109081
3.
4.

Matrix metalloproteinase 2 induces epithelial-mesenchymal transition in proximal tubules from the luminal side and progresses fibrosis in mineralocorticoid/salt-induced hypertensive rats.

Iwazu Y, Muto S, Hirahara I, Fujisawa G, Takeda S, Kusano E.

J Hypertens. 2011 Dec;29(12):2440-53. doi: 10.1097/HJH.0b013e32834c31f5.

PMID:
22045122
5.

Peritubular capillary regression during the progression of experimental obstructive nephropathy.

Ohashi R, Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N.

J Am Soc Nephrol. 2002 Jul;13(7):1795-805.

6.

Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury.

Fujisawa G, Okada K, Muto S, Fujita N, Itabashi N, Kusano E, Ishibashi S.

Hypertension. 2003 Mar;41(3):493-8. Epub 2003 Feb 17.

7.

Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor.

Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, Shim SI, Suki WN, Truong LD.

Hum Pathol. 2000 Dec;31(12):1491-7.

PMID:
11150374
8.

SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment.

Vallon V, Wyatt AW, Klingel K, Huang DY, Hussain A, Berchtold S, Friedrich B, Grahammer F, Belaiba RS, Görlach A, Wulff P, Daut J, Dalton ND, Ross J Jr, Flögel U, Schrader J, Osswald H, Kandolf R, Kuhl D, Lang F.

J Mol Med (Berl). 2006 May;84(5):396-404. Epub 2006 Apr 8.

PMID:
16604333
9.

Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.

Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ.

Am J Kidney Dis. 2001 Mar;37(3):601-11.

PMID:
11228186
10.

Thrombospondin-1 short hairpin RNA suppresses tubulointerstitial fibrosis in the kidney of ureteral obstruction by ameliorating peritubular capillary injury.

Sun D, Ma Y, Han H, Yin Z, Liu C, Feng J, Zhou X, Li X, Xiao A, Yu R.

Kidney Blood Press Res. 2012;35(1):35-47. doi: 10.1159/000330718. Epub 2011 Aug 19.

PMID:
21860248
11.

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats.

Fujisawa G, Okada K, Muto S, Fujita N, Itabashi N, Kusano E, Ishibashi S.

Kidney Int. 2004 Oct;66(4):1493-502.

PMID:
15458443
12.

Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy.

Sun D, Feng J, Dai C, Sun L, Jin T, Ma J, Wang L.

Am J Nephrol. 2006;26(4):363-71. Epub 2006 Jul 26.

PMID:
16873992
13.

Ginsenoside Rg1 modulation on thrombospondin-1 and vascular endothelial growth factor expression in early renal fibrogenesis in unilateral obstruction.

Xie XS, Liu HC, Wang FP, Zhang CL, Zuo C, Deng Y, Fan JM.

Phytother Res. 2010 Nov;24(11):1581-7. doi: 10.1002/ptr.3190.

PMID:
21031612
14.

Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.

Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, Hilgers KF.

Nephrol Dial Transplant. 2008 Nov;23(11):3456-63. doi: 10.1093/ndt/gfn301. Epub 2008 May 30.

15.

Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats.

Han KH, Kang YS, Han SY, Jee YH, Lee MH, Han JY, Kim HK, Kim YS, Cha DR.

Kidney Int. 2006 Jul;70(1):111-20. Epub 2006 May 24.

PMID:
16723984
16.
18.

Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats.

Bae EH, Kim IJ, Ma SK, Kim SW.

Hypertens Res. 2010 Mar;33(3):255-62. doi: 10.1038/hr.2009.217. Epub 2010 Jan 8.

PMID:
20057489
19.

Transplantation of endothelial progenitor cells alleviates renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction.

Ma YY, Sun D, Li J, Yin ZC.

Life Sci. 2010 May 22;86(21-22):798-807. doi: 10.1016/j.lfs.2010.03.013. Epub 2010 Mar 20.

PMID:
20331991
20.

CD44 disruption prevents degeneration of the capillary network in obstructive nephropathy via reduction of TGF-beta1-induced apoptosis.

Rouschop KM, Claessen N, Pals ST, Weening JJ, Florquin S.

J Am Soc Nephrol. 2006 Mar;17(3):746-53. Epub 2006 Feb 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk